David Linetsky Phreesia, Inc. (PHR) insider trading activity

PHR Quotes by TradingView

David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 229,751 shares of PHR, which is worth approximately $6.89 Million. The most recent transaction as insider was on Feb 07, 2025, when has been sold 300 shares (Common Stock) at a price of $29.52 per share, resulting in proceeds of $8,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 230K
14.76% 3M change
12.59% 12M change
Total Value Held $6.89 Million

David Linetsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2025
SELL
Open market or private sale
$8,856 $29.52 p/Share
300 Reduced 0.13%
229,751 Common Stock
Feb 05 2025
SELL
Open market or private sale
$21,240 $29.5 p/Share
720 Reduced 0.31%
230,051 Common Stock
Jan 29 2025
SELL
Open market or private sale
$14,840 $29.68 p/Share
500 Reduced 0.22%
230,771 Common Stock
Jan 27 2025
SELL
Open market or private sale
$323,323 $27.67 p/Share
11,685 Reduced 4.81%
231,271 Common Stock
Jan 23 2025
BUY
Grant, award, or other acquisition
-
19,564 Added 7.45%
242,956 Common Stock
Jan 21 2025
SELL
Open market or private sale
$378,871 $27.31 p/Share
13,873 Reduced 5.85%
223,392 Common Stock
Jan 15 2025
SELL
Open market or private sale
$52,503 $26.98 p/Share
1,946 Reduced 0.81%
237,265 Common Stock
Jan 06 2025
SELL
Open market or private sale
$83,369 $26.61 p/Share
3,133 Reduced 1.29%
239,211 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
53,990 Added 18.22%
242,344 Common Stock
Dec 11 2024
SELL
Open market or private sale
$294,547 $24.85 p/Share
11,853 Reduced 5.92%
188,354 Common Stock
Oct 18 2024
SELL
Open market or private sale
$22,539 $20.49 p/Share
1,100 Reduced 0.55%
200,207 Common Stock
Oct 15 2024
SELL
Open market or private sale
$42,291 $21.03 p/Share
2,011 Reduced 0.99%
201,307 Common Stock
Sep 10 2024
SELL
Open market or private sale
$39,897 $23.25 p/Share
1,716 Reduced 0.84%
203,318 Common Stock
Sep 06 2024
BUY
Grant, award, or other acquisition
-
2,816 Added 1.35%
205,034 Common Stock
Jul 16 2024
SELL
Open market or private sale
$43,206 $23.74 p/Share
1,820 Reduced 0.89%
202,218 Common Stock
Apr 15 2024
SELL
Open market or private sale
$50,566 $22.86 p/Share
2,212 Reduced 1.07%
204,038 Common Stock
Apr 08 2024
SELL
Open market or private sale
$89,317 $22.82 p/Share
3,914 Reduced 1.86%
206,250 Common Stock
Apr 05 2024
BUY
Grant, award, or other acquisition
-
6,105 Added 2.82%
210,164 Common Stock
Jan 17 2024
SELL
Open market or private sale
$739,495 $24.12 p/Share
30,659 Reduced 13.06%
204,059 Common Stock
Jan 16 2024
SELL
Open market or private sale
$56,906 $24.55 p/Share
2,318 Reduced 0.98%
234,718 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
22,000 Added 8.49%
237,036 Common Stock
Oct 16 2023
SELL
Open market or private sale
$34,515 $16.61 p/Share
2,078 Reduced 0.96%
215,036 Common Stock
Sep 13 2023
SELL
Open market or private sale
$42,724 $20.75 p/Share
2,059 Reduced 0.94%
217,114 Common Stock
Sep 12 2023
BUY
Exercise of conversion of derivative security
$68,984 $5.82 p/Share
11,853 Added 5.13%
219,173 Common Stock
Sep 12 2023
BUY
Grant, award, or other acquisition
-
3,279 Added 1.56%
207,320 Common Stock
DL

David Linetsky

SVP, Life Sciences
Raleigh, NC

Track Institutional and Insider Activities on PHR

Follow Phreesia, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

News

Receive news related to Phreesia, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHR